Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00071136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms

Interventions

DRUG: pemetrexed
DRUG: gemcitabine

Sponsor

Eli Lilly and Company